EPO and Alzheimer disease: These findings are in accordance with increasing evidence suggesting that age-related decreases of Epo expression in the hippocampal region may contribute to Alzheimer (AD), a disease well known to be associated with neurodegeneration and apoptosis which impair synaptic function [87–90].